Wellcare Healthcare Plans Inc. (WCG) soars on resumption of Medicare Advantage drugs

WellCare Health Plans Inc. (NYSE: WCG) said on Wednesday that it would start marketing Medicare drug and Medicare Advantage programs in the next few days. It has received approval against most of the government's fraud sanctions, earlier sanctioned on WellCare Health Plans Inc. (WCG).

WellCare Health Plans Inc. (WCG) stock, after opening at a 52 week high around $31.5 with a gap-up opening, however, started slipping in the mid day trades on "sell on news" and shrinked to $28.31.

Meanwhile, WellCare Health Plans Inc. (WCG) reported a profit of $28.7 million in Q3, or 68 cents per share. Excluding one-time costs, profit rose to 82 cents per share. The company took a loss of $18.2 million, or 44 cents per share, a year ago.


There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.